Phase 1 Drug Candidate GLR2007 Developed by Gan & Lee has been Granted Fast Track Designation by the U.S. FDA Read more
Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients Read more
Novartis signs initial agreement to provide manufacturing capacity for Pfizer-BioNTech COVID-19 vaccine Read more
Valneva Commences Manufacturing of its Inactivated, Adjuvanted COVID-19 Vaccine, Completes Phase 1/2 Study Recruitment Read more
Hoth Therapeutics Expands Research Collaboration Agreement with Weill Cornell Medicine to Continue the Advancement of HT-003 for Acne Treatment Research Read more
Running for the 3rd year this March 2-4 to unite cross-industry experts from nephrology, cardiology, and endocrinology the 3rd CKD3 Summit is focusing on the question “what’s next?” Read more
Sanofi to provide support to BioNTech in manufacturing their COVID-19 vaccine to help address public health needs Read more